Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesEfficacy of targeted therapy in patients with renal cell carcinoma with pre-existing or new bone metastases
Journal of Cancer Research & Clinical Oncology, 08/31/09
Zolnierek J et al. – Pre–existing metastatic bone lesions were reported in 82 patients, of which 30 experienced progression. Twenty–three of 210 patients developed new bone lesions. Overall, sunitinib appeared slightly more effective than sorafenib or IFN–alfa at extending mean time to progression of pre–existing bone lesions. Compared with sorafenib, sunitinib significantly decreased formation and prolonged time to occurrence of new bone lesions.
Related Articles
Effect of Collecting Duct Histology on Renal Cell Cancer Outcome
The Journal of Urology, 11/18/09
Relevance Score: 83%
Prognostic Value of Capsular Invasion for Localized Clear-Cell Renal Cell Carcinoma
European Urology, 11/10/09
Relevance Score: 83%
Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient
International Journal of Clinical Oncology, 10/30/09
Relevance Score: 83%
Prognostic factors for renal cell carcinoma: Trakya University experience from Turkey
European Journal of Cancer Care, 10/22/09
Relevance Score: 83%
The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival
The Journal of Urology, 10/14/09
Relevance Score: 83%
Today in Bone/Cartilage...keeping you current
Receive free subspecialty "5-minute updates" via email
Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1
British Journal of Cancer, 12/17/09
Epidermal growth factor signalling and bone metastasis
British Journal of Cancer, 12/17/09
Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis
Oncogene, 12/17/09
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension
Human Pathology, 12/19/09
Papillary renal cell carcinoma with diffuse clear cells and thyroid-like macrofollicular areas
Annals of Diagnostic Pathology, 12/19/09
Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence
Medical Oncology, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor